Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts. more
Time Frame | LNTH | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.03% | -3.35% | -2.97% |
1-Month Return | 15.75% | -3.49% | -0.66% |
3-Month Return | -15.31% | -12.6% | 2.71% |
6-Month Return | 12.84% | -6.91% | 7.21% |
1-Year Return | 53.5% | 1.19% | 23.04% |
3-Year Return | 234.08% | -0.21% | 28.43% |
5-Year Return | 336.77% | 33.09% | 82.88% |
10-Year Return | 1432.33% | 93.55% | 184.63% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 347.34M | 339.41M | 425.21M | 935.06M | 1.30B | [{"date":"2019-12-31","value":26.79,"profit":true},{"date":"2020-12-31","value":26.18,"profit":true},{"date":"2021-12-31","value":32.8,"profit":true},{"date":"2022-12-31","value":72.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 172.53M | 200.65M | 237.51M | 353.36M | 586.89M | [{"date":"2019-12-31","value":29.4,"profit":true},{"date":"2020-12-31","value":34.19,"profit":true},{"date":"2021-12-31","value":40.47,"profit":true},{"date":"2022-12-31","value":60.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 174.81M | 138.76M | 187.69M | 581.70M | 709.54M | [{"date":"2019-12-31","value":24.64,"profit":true},{"date":"2020-12-31","value":19.56,"profit":true},{"date":"2021-12-31","value":26.45,"profit":true},{"date":"2022-12-31","value":81.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 50.33% | 40.88% | 44.14% | 62.21% | 54.73% | [{"date":"2019-12-31","value":80.9,"profit":true},{"date":"2020-12-31","value":65.72,"profit":true},{"date":"2021-12-31","value":70.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.98,"profit":true}] |
Operating Expenses | 123.15M | 142.96M | 263.78M | 545.51M | 344.90M | [{"date":"2019-12-31","value":22.58,"profit":true},{"date":"2020-12-31","value":26.21,"profit":true},{"date":"2021-12-31","value":48.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.23,"profit":true}] |
Operating Income | 32.06M | (4.20M) | (76.09M) | (13.44M) | 364.64M | [{"date":"2019-12-31","value":8.79,"profit":true},{"date":"2020-12-31","value":-1.15,"profit":false},{"date":"2021-12-31","value":-20.87,"profit":false},{"date":"2022-12-31","value":-3.68,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (16.36M) | (16.52M) | (21.92M) | (14.05M) | 45.92M | [{"date":"2019-12-31","value":-35.64,"profit":false},{"date":"2020-12-31","value":-35.98,"profit":false},{"date":"2021-12-31","value":-47.74,"profit":false},{"date":"2022-12-31","value":-30.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 28.63M | (11.48M) | (75.04M) | 26.72M | 410.94M | [{"date":"2019-12-31","value":6.97,"profit":true},{"date":"2020-12-31","value":-2.79,"profit":false},{"date":"2021-12-31","value":-18.26,"profit":false},{"date":"2022-12-31","value":6.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | (3.04M) | 1.99M | (3.76M) | (1.35M) | 84.28M | [{"date":"2019-12-31","value":-3.61,"profit":false},{"date":"2020-12-31","value":2.37,"profit":true},{"date":"2021-12-31","value":-4.46,"profit":false},{"date":"2022-12-31","value":-1.6,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 31.67M | (13.47M) | (71.28M) | 28.07M | 326.66M | [{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 31.67M | (13.47M) | (71.28M) | 28.07M | 326.66M | [{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 31.67M | (13.47M) | (71.28M) | 28.07M | 326.66M | [{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 1.17 | 0.57 | 0.49 | 4.22 | 6.23 | [{"date":"2019-12-31","value":18.78,"profit":true},{"date":"2020-12-31","value":9.15,"profit":true},{"date":"2021-12-31","value":7.87,"profit":true},{"date":"2022-12-31","value":67.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
LNTH | |
---|---|
Cash Ratio | 1.10 |
Current Ratio | 1.65 |
Quick Ratio | 1.56 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LNTH | |
---|---|
ROA (LTM) | 17.00% |
ROE (LTM) | 45.53% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
LNTH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.42 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.58 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LNTH | |
---|---|
Trailing PE | 15.39 |
Forward PE | 12.00 |
P/S (TTM) | 4.30 |
P/B | 5.46 |
Price/FCF | 40 |
EV/R | 4.14 |
EV/Ebitda | 9.50 |
PEG | 0.61 |
Lantheus Holdings Inc (LNTH) share price today is $91.94
Yes, Indians can buy shares of Lantheus Holdings Inc (LNTH) on Vested. To buy Lantheus Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LNTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Lantheus Holdings Inc (LNTH) via the Vested app. You can start investing in Lantheus Holdings Inc (LNTH) with a minimum investment of $1.
You can invest in shares of Lantheus Holdings Inc (LNTH) via Vested in three simple steps:
The 52-week high price of Lantheus Holdings Inc (LNTH) is $126.89. The 52-week low price of Lantheus Holdings Inc (LNTH) is $50.2.
The price-to-earnings (P/E) ratio of Lantheus Holdings Inc (LNTH) is 15.392
The price-to-book (P/B) ratio of Lantheus Holdings Inc (LNTH) is 5.46
The dividend yield of Lantheus Holdings Inc (LNTH) is 0.00%
The market capitalization of Lantheus Holdings Inc (LNTH) is $6.44B
The stock symbol (or ticker) of Lantheus Holdings Inc is LNTH